Nitazoxanide CAS 55981-09-4: Your Leading Pharmaceutical Intermediate
Discover the broad-spectrum antiparasitic and antiviral capabilities of Nitazoxanide, a key pharmaceutical intermediate for treating a wide array of infections. Explore its applications and why sourcing from China's leading suppliers is essential for your research and production needs.
Get a Quote & SampleUnlocking the Power of Nitazoxanide
Nitazoxanide CAS 55981-09-4
As a premier supplier in China, we provide high-quality Nitazoxanide, a critical pharmaceutical intermediate renowned for its broad-spectrum antiparasitic and antiviral properties. Our commitment to excellence ensures you receive a product with minimum 99.00% purity, essential for effective therapeutic applications. We are a trusted manufacturer, offering competitive pricing for bulk orders.
- Discover the efficacy of this broad-spectrum antiparasitic drug in treating various helminthic and protozoal infections.
- Explore its potential as an antiviral medication for influenza and other viral pathogens, aiding in your research.
- Benefit from the consistent quality and reliability of a leading pharmaceutical intermediate manufacturer based in China.
- Secure a cost-effective supply chain by choosing a dedicated Nitazoxanide supplier with proven expertise.
Key Advantages of Nitazoxanide
Broad-Spectrum Efficacy
Leverage the power of a broad-spectrum antiparasitic drug that effectively combats a wide range of parasitic infections, crucial for developing effective treatments.
Antiviral Potential
Investigate its promising role as an antiviral medication, particularly for influenza, and its potential in emerging viral threats like COVID-19.
High Purity Standards
Ensure your pharmaceutical formulations meet stringent quality requirements with our Nitazoxanide, boasting a purity of ≥99.00%, a testament to our manufacturing capabilities.
Primary Applications
Gastrointestinal Infections
Treating diarrhea caused by parasitic infections is a primary use, making it a vital component for pharmaceutical companies addressing public health concerns.
Hepatitis Treatment
Ongoing research highlights Nitazoxanide's potential in managing chronic hepatitis B and C, opening new avenues for therapeutic development.
Viral Infections
Its demonstrated efficacy against various viruses, including influenza, positions it as a key compound for developing next-generation antiviral treatments.
COVID-19 Research
Early studies suggest Nitazoxanide as a promising early treatment for COVID-19, underscoring its versatility and importance in pharmaceutical research.